Practical management of anticoagulation, bleeding and blood product support for cardiac surgery. Part two: Transfusion issues

Heart Lung and Circulation

Volumn 11, Issue 1, 2002, Pages 42-51

  Robinson, Kathryn L ^a   Marasco, Silvana F ^b   Street, Alison M ^c  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b CJOB Cardiothoracic Unit   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Blood conservation; Blood products; Cardiac surgery; Cardiopulmonary bypass; Leucodepletion; Transfusion reactions

Indexed keywords

COLD AGGLUTININ;

ANEMIA; ANTICOAGULATION; AUSTRALIA; BLEEDING DISORDER; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BLOOD VOLUME; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; GRAFT VERSUS HOST REACTION; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; INFECTION RISK; IRRADIATION; LEUKOPENIA; PHYSICIAN; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECIPIENT; REVIEW; RISK ASSESSMENT; SCREENING TEST; SEROLOGY;

EID: 0036239920     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1444-2892.2002.00109.x     Document Type: Review

References (57)

1. Results of viral marker screening of unpaid blood donations and probability of window period donations in 1997
2. Addressing Patient Concerns About Transfusion Transmissible Infections
3. Leukocyte-reduced blood transfusions: Perioperative indications, adverse effects, and cost analysis
4. Neuro-immune connection in spread of prions in the body?
5. Immunomodulatory effects of allogeneic blood transfusions: Clinical manifestations and mechanisms
6. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial
7. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant
8. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes
9. Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection. J
10. Leucocyte depletion of the blood supply - How will patients benefit?
11. Modifying risk for extracorporeal circulation: Trial of four antiinflammatory strategies
12. Diagnosis and management of transfusion reactions
13. From the Food and Drug Administration
14. Transfusion-related acute lung injury
15. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting
16. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients
17. The irradiation of blood and blood components to prevent graft-versus-host disease: Technical issues and guidelines
18. Practice parameter for the use of red blood cell transfusions: Developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists
19. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: A 24-institution study. Institutions
20. Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome
21. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: Implications for a bloodless surgical technique
22. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients
23. Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery
24. Guidelines for transfusion support in patients undergoing coronary artery bypass grafting
25. ABC of clinical haematology. Iron deficiency anaemia
26. Consensus conference on autologous transfusion. Preoperative autologous donation
27. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting
28. Cost-effectiveness of epoetin and autologous blood donation in reducing allogeneic blood transfusions in coronary artery bypass graft surgery
29. Transfusion medicine. Second of two parts - Blood conservation
30. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: Results of a meta-analysis
31. Guidelines for autologous transfusion. II. Perioperative haemodilution and cell salvage
32. Reduction in homologous blood transfusions using a low prime circuit
33. Retrograde autologous priming for cardiopulmonary bypass: A safe and effective means of decreasing hemodilution and transfusion requirements
34. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery
35. Guidelines for red blood cell and plasma transfusion for adults and children
36. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy
37. Oxygen extraction ratio: A valid indicator of myocardial metabolism in anemia
38. Oxygen extraction ratio: A valid indicator of transfusion need in limited coronary vascular reserve?
39. Limit to cardiac compensation during acute isovolemic hemodilution: Influence of coronary stenosis
40. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care
41. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity
42. Does transfusion practice affect mortality in critically ill patients?
43. Comparison of two transfusion strategies after elective operations for myocardial revascularization
44. Conservation of blood during cardiovascular surgery
45. Cardiac surgery and cold-reactive proteins
46. Detection of cold hemagglutination in a blood cardioplegia unit before systemic cooling of a patient with unsuspected cold agglutinin disease
47. Cold hemagglutination pathophysiology. Evaluation and management of patients undergoing cardiac surgery with induced hypothermia
48. Cold agglutinins and hypothermia
49. The effect of hypothermic cardiopulmonary bypass on patients with low-titer, nonspecific cold agglutinins
50. Increased pressures in the retrograde blood cardioplegia line: An unusual presentation of cold agglutinins during cardiopulmonary bypass
51. Intermediate lukewarm (20 degrees c) antegrade intermittent blood cardioplegia compared with cold and warm blood cardioplegia
52. Changing temperature management for cardiopulmonary bypass
53. Case 6-1993. Cardiopulmonary bypass in two patients with previously undetected cold agglutinins
54. Cardiopulmonary bypass and myocardial protection: Management problems in cardiac surgical patients with cold autoimmune disease
55. Transfusion medicine. First of two parts - Blood transfusion